Trade AbbVie ^ABBV

AbbVie (NYSE:ABBV) Trading Up 1.6% After Dividend Announcement - Zolmax

Saudi Central Bank Has $31.16 Million Stock Holdings in AbbVie Inc. $ABBV

10,631 Shares in AbbVie Inc. $ABBV Bought by Markowski Investments

NBH Bank Takes $1.81 Million Position in AbbVie Inc. $ABBV

MW Advisory LLC Acquires New Stake in AbbVie Inc. $ABBV

Compass Financial Management LLC Invests $2.76 Million in AbbVie Inc. $ABBV

Why Did Billionaire Israel "Izzy" Englander More Than Double His Stake in AbbVie Stock and Start a Position in SpaceX Stock?

AbbVie's Atogepant Meets Goal in Late-Stage Menstrual Migraine Study

AbbVie Inc. (NYSE:ABBV) Declares Quarterly Dividend of $1.73

ABBV Looks 15.8% Overvalued on GF Value™ as Dividend Sustainabil

TD Waterhouse Canada Inc. Trims Position in AbbVie Inc. $ABBV

NEOS Investment Management LLC Has $72.07 Million Stock Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Stock Holdings Increased by Munich Reinsurance Co Stock Corp in Munich

Prosperitas Financial LLC Has $5.62 Million Holdings in AbbVie Inc. $ABBV - Stock Observer

Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Pyxis Oncology (PYXS)

RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)

TD Waterhouse Canada Inc. Decreases Position in AbbVie Inc. $ABBV - Daily Political

Endometriosis Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments - DelveInsight | AbbVie, Kissei Pharma, Theramex, Hope Medicine, TiumBio, Viramal, Organon | ABNewswire

Plaque Psoriasis Market Expected to Gain Momentum Through 2034, According to DelveInsight | ABNewswire

AbbVie (NYSE:ABBV) Shares Up 1.6% - What's Next? - Markets Daily

AbbVie (NYSE:ABBV) Stock Price Up 1.6% - Still a Buy?

AbbVie (NYSE:ABBV) Stock Price Down 3% - Should You Sell? - Zolmax

AbbVie Gains as Qulipta Opens a New Migraine Market

AbbVie's Immunology Franchise: From Skyrizi & Rinvoq to What's Next

AbbVie's Menstrual Migraine Treatment Meets Primary, Secondary Endpoints in Phase 3 Trial | Morningstar

Nykredit A S Makes New Investment in AbbVie Inc. $ABBV

Allen Mooney & Barnes Investment Advisors LLC Has $20.63 Million Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Position Increased by PYA Waltman Capital LLC - Daily Political

Antibody Drug Conjugates Market Poised for Significant Growth Through 2034, Driven by Expanding Oncology Applications, Next-generation ADCs, and Advances in Targeted Cancer Therapy | DelveInsight | ABNewswire

Non-Hodgkin Lymphoma Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma, Eli Lilly | ABNewswire

Is AbbVie (ABBV)'s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth?

AbbVie Highlights SKYRIZI, RINVOQ Growth and Pipeline Catalysts at Wells Fargo Conference

AbbVie Inc. $ABBV Shares Sold by Railway Pension Investments Ltd

Proficio Capital Partners LLC Grows Holdings in AbbVie Inc. $ABBV

Independence Bank of Kentucky Purchases 4,120 Shares of AbbVie Inc. $ABBV

Jackson Wealth Management LLC Has $1.03 Million Stake in AbbVie Inc. $ABBV

CTC Alternative Strategies Ltd. Takes Position in AbbVie Inc. $ABBV

Ancora Advisors LLC Reduces Stock Position in AbbVie Inc. $ABBV

Nwam LLC Has $6.88 Million Stock Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie (ABBV) Registers a Bigger Fall Than the Market: Important Facts to Note

Is AbbVie Stock Too Reliant On Skyrizi?

Royal London Asset Management Ltd. Reduces Stake in AbbVie Inc. $ABBV

Washington Trust Bank Sells 5,155 Shares of AbbVie Inc. $ABBV

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 106,091 Shares of AbbVie Inc. $ABBV

Cullinan Associates Inc. Lowers Position in AbbVie Inc. $ABBV

Flputnam Investment Management Co. Has $26.56 Million Stake in AbbVie Inc. $ABBV

Mufg Securities Americas Inc. Purchases 4,319 Shares of AbbVie Inc. $ABBV

New Mexico Educational Retirement Board Purchases 6,700 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Royal London Asset Management Ltd. - Daily Political

Promising Biotech Stocks To Consider - September 7th - Zolmax

Pharmaceutical Stocks To Watch Today - September 7th - Stock Observer

Beacon Pointe Advisors LLC Reduces Holdings in AbbVie Inc. $ABBV

Ferguson Wellman Capital Management Inc. Has $165.27 Million Stock Holdings in AbbVie Inc. $ABBV

Field & Main Bank Takes $2.70 Million Position in AbbVie Inc. $ABBV

421,257 Shares in AbbVie Inc. $ABBV Acquired by Glenview Trust Co

BNP Paribas Acquires 11,318 Shares of AbbVie Inc. $ABBV

Empowered Funds LLC Sells 24,477 Shares of AbbVie Inc. $ABBV

8,198 Shares in AbbVie Inc. $ABBV Bought by Fulcrum Asset Management LLP

Dearborn Partners LLC Makes New Investment in AbbVie Inc. $ABBV

Livforsakringsbolaget Skandia Omsesidigt Raises Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. $ABBV Shares Sold by Wellington Management Group LLP - Daily Political

Jefferies Financial Group Inc. Grows Holdings in AbbVie Inc. $ABBV - Markets Daily

Jefferies Financial Group Inc. Purchases 59,905 Shares of AbbVie Inc. $ABBV - Zolmax

Public Employees Retirement System of Ohio Cuts Holdings in AbbVie Inc. $ABBV - Markets Daily

Proficio Capital Partners LLC Increases Holdings in AbbVie Inc. $ABBV

Redwood Investment Management LLC Acquires Shares of 4,348 AbbVie Inc. $ABBV

Public Employees Retirement System of Ohio Decreases Stake in AbbVie Inc. $ABBV

Corient Private Wealth LP Takes Position in AbbVie Inc. $ABBV

Equitable Holdings Inc. Decreases Stock Holdings in AbbVie Inc. $ABBV

Corient Private Wealth LP Has $4.92 Million Stock Holdings in AbbVie Inc. $ABBV

Hamilton Capital LLC Grows Stock Position in AbbVie Inc. $ABBV

Dearborn Partners LLC Sells 13,811 Shares of AbbVie Inc. $ABBV

Fayez Sarofim & Co Boosts Stock Position in AbbVie Inc. $ABBV

Pure Financial Advisors LLC Acquires 3,858 Shares of AbbVie Inc. $ABBV - Daily Political

Healthcare Stocks To Consider - September 5th - Stock Observer

Gallagher Fiduciary Advisors LLC Invests $1.39 Million in AbbVie Inc. $ABBV - Zolmax

3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King)

Strategic Global Advisors LLC Takes Position in AbbVie Inc. $ABBV

Wallace Capital Management Inc. Takes Position in AbbVie Inc. $ABBV

PDT Partners LLC Invests $8.86 Million in AbbVie Inc. $ABBV

8,842 Shares in AbbVie Inc. $ABBV Bought by Royal Capital Wealth Management LLC

Roberts Glore & Co. Inc. IL Invests $7.41 Million in AbbVie Inc. $ABBV

70,905 Shares in AbbVie Inc. $ABBV Bought by Palisade Capital Management LP

The Manufacturers Life Insurance Company Acquires New Position in AbbVie Inc. $ABBV

EFG International AG Takes Position in AbbVie Inc. $ABBV

25,696 Shares in AbbVie Inc. $ABBV Bought by Kinloch Capital LLC

Jupiter Topco LLC Takes Position in AbbVie Inc. $ABBV

Osterweis Capital Management Inc. Makes New Investment in AbbVie Inc. $ABBV - Stock Observer

Magnolia Capital Advisors LLC Invests $4.21 Million in AbbVie Inc. $ABBV - Daily Political

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie (NYSE:ABBV) Shares Down 1.5% - Time to Sell? - Stock Observer

AbbVie's Humira Cash Cow Is Shrinking-Can Its Dividend Keep Growing?

Here Are 5 ETFs That Retirees Use to Skip Stock Picking Entirely

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Fed, ECB & BoJ in action

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk